Observed Side Effects (From Clinical Trials) In the Lancet 2021 Phase 2 trial (n=706), at the highest 4.5 mg/week dose, 88% of participants reported at least one side effect and 63% reported a GI-specific event
Dieser umfasst gastrointestinale Heilung, Bewegungsapparat-Reparatur, neuroprotektive Wirkungen und systemische Entzndungshemmung
Likewise, consuming kale juice for six weeks had a different impact based on GST subtype, especially in the vitamin C levels and DNA damage, with the GSTM1 null genotype experiencing the best impact from the kale juice
Jakkampudi A, Jangala R, Reddy BR, Mitnala S, Nageshwar Reddy D, Talukdar R
For context, the Phase 2 study (Jastreboff 2023, NEJM) reported about 17.5 percent mean weight reduction at 24 weeks on 12 mg